How to Get Lamzede (velmanase alfa-tycv) Covered by Blue Cross Blue Shield in Pennsylvania: Prior Authorization Guide
Quick Answer: Blue Cross Blue Shield requires prior authorization for Lamzede (velmanase alfa-tycv) in Pennsylvania. You'll need confirmed alpha-mannosidosis diagnosis with enzyme activity below 11% of normal, documentation of non-CNS manifestations, and agreement to monitor for infusion reactions. If denied, Pennsylvania's new external review program overturns